Allopregnanolone concentration and mood—a bimodal association in postmenopausal women treated with oral progesterone
- 25 May 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Psychopharmacology
- Vol. 187 (2), 209-221
- https://doi.org/10.1007/s00213-006-0417-0
Abstract
Allopregnanolone effects on mood in postmenopausal women are unclear thus far. Allopregnanolone is a neuroactive steroid with contradictory effects. Anaesthetic, sedative, and anxiolytic as well as aggressive and anxiogenic properties have been reported. The aim of this study is to compare severity of negative mood between women receiving different serum allopregnanolone concentrations during progesterone treatment. A randomized, placebo-controlled, double-blind, crossover study of postmenopausal women (n=43) treated with 2 mg estradiol daily during four treatment cycles. Oral micronized progesterone at 30, 60, and 200 mg/day, and placebo were added sequentially to each cycle. Participants kept daily symptom ratings using a validated rating scale. Blood samples for progesterone and allopregnanolone analyses were collected during each treatment cycle. During progesterone treatment, women had significantly higher negative mood scores when allopregnanolone serum concentration was in the range of 1.5–2 nmol/l compared to lower and higher concentrations. In addition, women displayed a significant increase in negative mood during the progesterone treatment period, compared to the estradiol-only period when 30 mg progesterone daily was used. On the other hand, treatment with higher doses of progesterone had no influence on negative mood. Mood effects during progesterone treatment seem to be related to allopregnanolone concentration, and a bimodal association between allopregnanolone and adverse mood is evident.Keywords
This publication has 60 references indexed in Scilit:
- Estradiol and the addition of progesterone increase the sensitivity to a neurosteroid in postmenopausal womenPsychoneuroendocrinology, 2005
- The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapyGynecological Endocrinology, 2002
- Differential Behavioral Effects of Gonadal Steroids in Women with and in Those without Premenstrual SyndromeNew England Journal of Medicine, 1998
- Interaction between 3α‐hydroxy‐5α‐pregnan‐20‐one and carbachol in the control of neuronal excitability in hippocampal slices of female rats in defined phases of the oestrusActa Physiologica Scandinavica, 1998
- Anxiolytic Effect of Progesterone is Mediated by the Neurosteroid Allopregnanolone at Brain GABAA ReceptorsJournal of Neuroendocrinology, 1995
- Severe Negative Emotional Reactions in Intracarotid Sodium Amytal Procedures: Further Evidence For Hemispheric Asymmetries?Cortex, 1991
- Acute and chronic effects of psychotropic drugs on maternal aggression in micePsychopharmacology, 1989
- The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndromeBJOG: An International Journal of Obstetrics and Gynaecology, 1986
- Steroid Hormone Metabolites Are Barbiturate-Like Modulators of the GABA ReceptorScience, 1986
- Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsyActa Neurologica Scandinavica, 1984